Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,553 | 0 | N/A | N/A | N/A |
| Receivables | 3,276 | 0 | N/A | N/A | N/A |
| Other current assets | 1,811 | 0 | 0 | 0 | 0 |
| TOTAL | $12,640 | $0 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 8,480 | 0 | N/A | N/A | N/A |
| Other Non-Current Assets | 2,368 | 0 | 0 | 0 | 0 |
| TOTAL | $10,848 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $23,488 | $0 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,080 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,579 | 0 | 0 | 0 | 0 |
| TOTAL | $7,895 | $0 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,363 | 0 | N/A | N/A | N/A |
| Deferred Revenues | 3,236 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,642 | 0 | 0 | 0 | 0 |
| TOTAL | $5,341 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,236 | $0 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 5,122 | 0 | N/A | N/A | N/A |
| Retained earnings | -4,716 | 0 | N/A | N/A | N/A |
| Other shareholders' equity | 7,546 | 0 | 0 | 0 | 0 |
| TOTAL | $10,252 | $0 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $23,488 | $0 | $0 | $0 | $0 |